Skip to content

Batch information on every product pageTHC < 0.3%Shipped from France10% off when you sign up

MK-9470

PET tracer of the human CB1 receptor, inverse agonist (IC50 0.7 nM).

Level of detail

C₂₉H₃₂FN₃O₃

CAS 947371-30-4

Family
ECS pharmacological toolAntagonist or inverse agonist
Molar mass
489.60 g/mol

Updated on

In plain terms

MK-9470 is used to photograph CB1 receptors in a living brain. Labelled with a short-lived radioactive atom, it binds to these receptors and makes their distribution visible to a camera. It is a research imaging tool, not a treatment.

Receptors and activity

Target network

CB1Inverse agonistIC50 = 0.7 nM · humanIC50 at human CB1 (abstract; preparation not specified); selective and high-affinity; inverse agonist; fluorine-18 labelled for PET
  • Blocks or inhibits

The lower the cited value, the closer the target sits to MK-9470: one ring per factor of 100. A target with no measured value stays on the edge.

Where these targets live

Where each target has been found in humans, according to the cited studies. The map shows the target, not an effect of MK-9470.

Brain, side view
Body, front view
Blood

CB1CB1 found in 7 regions of the body

  1. Basal gangliadenseMost dense in basal ganglia outflow nuclei1
  2. CerebellumdenseVery dense in the cerebellum1
  3. HippocampusdenseVery high concentrations in the hippocampus2
  4. AmygdaladenseHigh concentrations in the amygdala2
  5. CortexpresentPresent throughout the neocortex2
  6. Adipose tissuepresentExpressed in adipose tissue3
  7. GutpresentColonic epithelium, smooth muscle and plexus4

Cited values

  1. CB1Inverse agonistIC50 = 0.7 nM · human86 out of 100

    Burns et al., Proc Natl Acad Sci U S A 2007 (new tab) · IC50 at human CB1 (abstract; preparation not specified); selective and high-affinity; inverse agonist; fluorine-18 labelled for PET

Bar length follows the measured value (Ki, Kd, EC50 or IC50), on one scale shared by every entry, from 100 µM to 0.1 nM. A target with no cited value has no bar.

Measured effects

Not characterised. No placebo-controlled human trial has measured the effects of MK-9470, so no level is shown.

Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method

Pharmacology

[18F]MK-9470 is a positron emission tomography (PET) tracer of the CB1 receptor, developed for human brain imaging. Described in 2007 by Burns and colleagues, it is a selective high-affinity inverse agonist (human IC50 0.7 nM) labelled with fluorine-18. In autoradiography on rhesus monkey brain its binding follows the known distribution of CB1; in PET in monkeys, brain uptake is high, the ratio of total to nonspecific binding reaches 4 to 5 in the putamen, and the signal is blocked by pretreatment with the inverse agonist MK-0364 and reversible by displacement. In volunteers the tracer behaves like in monkeys, with a test-retest variability of 7%, and oral MK-0364 given to healthy young men produced a dose-related reduction in binding reflecting CB1 occupancy by the drug (Burns et al. 2007). In 50 healthy volunteers aged 18 to 69, CB1 binding increased with age in women only (Van Laere et al. 2008). In 10 chronic cannabis users examined within a week of last use, CB1 availability was 11.7% lower overall than in 10 age-matched controls (Ceccarini et al. 2015). The tracer serves research; it has no therapeutic purpose.

History

Source
An entirely synthetic compound with no natural occurrence. Its useful form, [18F]MK-9470, is labelled with fluorine-18, a short-lived radionuclide produced in a cyclotron (Burns et al. 2007).

Origin

Research tool

No biological pathway: MK-9470 is a synthetic compound of the acyclic amide class, unrelated to the plant cannabinoid pathway.

Classification

Family, origin and source verification

Family

ECS pharmacological tool › Antagonist or inverse agonist

Verification

Classification, sources and binding values checked on 20 October 2026; text read against its sources and Wikipedia.

Wikipedia (English)

MK-9470 (new tab)

Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.

References

Identifiers

Names

IUPAC name
N-[(2S,3S)-3-(3-cyanophenyl)-4-[4-(2-fluoroethoxy)phenyl]butan-2-yl]-2-methyl-2-[(5-methyl-2-pyridinyl)oxy]propanamide
Other names
[18F]MK-9470 · MK 9470

Identifiers

Formula
C₂₉H₃₂FN₃O₃
CAS
947371-30-4
InChIKey
XIYPJXKEMLKFMD-HFZDXXHNSA-N
SMILES
CC1=CN=C(C=C1)OC(C)(C)C(=O)N[C@@H](C)[C@@H](CC2=CC=C(C=C2)OCCF)C3=CC=CC(=C3)C#N

Machine-readable entry (JSON)

LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.